PUBLIX SUPER MARKETS INC
- Product NDC
- 56062-305
- 11-digit product format
- 560620305
- Labeler code
- 56062
- Product ID
- 56062-305_2abae08c-8123-18a0-e063-6394a90a94ae
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- ACETAMINOPHEN, ASPIRIN and CAFFEINE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- PUBLIX SUPER MARKETS INC
- Application
- ANDA214039
- Marketing category
- ANDA
- Marketing start
- 2024-02-23
- Substance
- ACETAMINOPHEN; ASPIRIN; CAFFEINE
- Active strength
- 250; 250; 65 mg/1; mg/1; mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A214039-001 | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | ACETAMINOPHEN; ASPIRIN; CAFFEINE | 250MG;250MG;65MG | TABLET / ORAL | 2021-02-23 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A214039-001 | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | 250MG;250MG;65MG | TABLET / ORAL | 2021-02-23 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A214039-001 | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | 250MG;250MG;65MG | TABLET / ORAL | 2021-02-23 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A214039-001 | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | 250MG;250MG;65MG | TABLET / ORAL | 2021-02-23 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A214039-001 | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | 250MG;250MG;65MG | TABLET / ORAL | 2021-02-23 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A214039-001 | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | 250MG;250MG;65MG | TABLET / ORAL | 2021-02-23 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A214039-001 | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | 250MG;250MG;65MG | TABLET / ORAL | 2021-02-23 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A214039-001 | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | 250MG;250MG;65MG | TABLET / ORAL | 2021-02-23 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A214039-001 | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | 250MG;250MG;65MG | TABLET / ORAL | 2021-02-23 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A214039-001 | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | 250MG;250MG;65MG | TABLET / ORAL | 2021-02-23 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A214039-001 | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | 250MG;250MG;65MG | TABLET / ORAL | 2021-02-23 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A214039-001 | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | 250MG;250MG;65MG | TABLET / ORAL | 2021-02-23 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A214039-001 | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | 250MG;250MG;65MG | TABLET / ORAL | 2021-02-23 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A214039-001 | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | 250MG;250MG;65MG | TABLET / ORAL | 2021-02-23 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A214039-001 | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | 250MG;250MG;65MG | TABLET / ORAL | 2021-02-23 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A214039-001 | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | 250MG;250MG;65MG | TABLET / ORAL | 2021-02-23 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A214039-001 | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | 250MG;250MG;65MG | TABLET / ORAL | 2021-02-23 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A214039-001 | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | 250MG;250MG;65MG | TABLET / ORAL | 2021-02-23 | 4b0b4de00fa7… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A214039-001 | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | 250MG;250MG;65MG | TABLET / ORAL | 2021-02-23 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A214039-001 | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | 250MG;250MG;65MG | TABLET / ORAL | 2021-02-23 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A214039-001 | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | 250MG;250MG;65MG | TABLET / ORAL | 2021-02-23 | 87673890dc5c… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A214039-001 | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | 250MG;250MG;65MG | TABLET / ORAL | 2021-02-23 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A214039-001 | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | 250MG;250MG;65MG | TABLET / ORAL | 2021-02-23 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A214039-001 | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | 250MG;250MG;65MG | TABLET / ORAL | 2021-02-23 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A214039-001 | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | 250MG;250MG;65MG | TABLET / ORAL | 2021-02-23 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A214039-001 | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | 250MG;250MG;65MG | TABLET / ORAL | 2021-02-23 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A214039-001 | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | 250MG;250MG;65MG | TABLET / ORAL | 2021-02-23 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A214039-001 | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | 250MG;250MG;65MG | TABLET / ORAL | 2021-02-23 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A214039-001 | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | 250MG;250MG;65MG | TABLET / ORAL | 2021-02-23 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A214039-001 | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | 250MG;250MG;65MG | TABLET / ORAL | 2021-02-23 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A214039-001 | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | 250MG;250MG;65MG | TABLET / ORAL | 2021-02-23 | 3a93d1ddd44b… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A214039-001 | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | 250MG;250MG;65MG | TABLET / ORAL | 2021-02-23 | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A214039-001 | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | 250MG;250MG;65MG | TABLET / ORAL | 2021-02-23 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A214039-001 | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | 250MG;250MG;65MG | TABLET / ORAL | 2021-02-23 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A214039-001 | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | 250MG;250MG;65MG | TABLET / ORAL | 2021-02-23 | a50c72e98297… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- PUBLIX SUPER MARKETS INC
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ACETAMINOPHEN | 250 mg/1 |
| ASPIRIN | 250 mg/1 |
| CAFFEINE | 65 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 362O9ITL9D | Internal UNII lookup |
| R16CO5Y76E | Internal UNII lookup |
| 3G6A5W338E | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 308297 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 08a46808-2bb2-0b40-e063-6394a90af80e | Available on FDA.report |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 56062-305-02 | PUBLIX SUPER MARKETS INC | 50 in 1 BOTTLE, PLASTIC | TABLET | 50 | 3 | |
| 56062-305-02 | PUBLIX SUPER MARKETS INC | 1 in 1 CARTON | TABLET | 1 | 3 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Migraine Relief | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | HARRIS TEETER | ff32572c-393b-0b49-e053-6394a90a83da | 2026-08-05 | Warnings | 214039 ANDA214039 |
| Migraine Relief | ACETAMINOPHEN, ASPIRIN, CAFFEINE | Family Dollar (FAMILY WELLNESS) | bfcffa70-94a9-43de-9f22-4ed6a71c0a8d | 2026-01-29 | Warnings | 214039 ANDA214039 |
| Acetaminophen, Aspirin and Caffeine | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | Safeway, Inc | f2a2cbb5-5a63-7514-e053-2995a90a572c | 2025-12-19 | Warnings | 214039 ANDA214039 |
| Acetaminophen Aspirin Caffeine | ACETAMINOPHEN ASPIRIN CAFFEINE | CVS PHARMACY, INC | c340c5ef-e15d-53ce-e053-2995a90a73e7 | 2025-12-19 | Warnings | 214039 ANDA214039 |
| Acetaminophen Aspirin Caffeine | ACETAMINOPHEN ASPIRIN CAFFEINE | WALGREEN CO | c32c8cbd-5775-afe3-e053-2995a90a81cb | 2025-12-19 | Warnings | 214039 ANDA214039 |
| Acetaminophen, Aspirin and Caffeine | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | FAMILY DOLLAR | f837e190-6fb3-e22e-e053-6394a90a12e6 | 2025-12-19 | Warnings | 214039 ANDA214039 |
| Acetaminophen, Aspirin and Caffeine | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | Granules India Ltd | e9534a13-ee8f-470f-8dd1-8ef0ce68526a | 2025-12-01 | Warnings | 214039 ANDA214039 |
| PUBLIX SUPER MARKETS INC | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | PUBLIX SUPER MARKETS INC | 08a46808-2bb2-0b40-e063-6394a90af80e | 2025-01-02 | Warnings | 214039 ANDA214039 56062-305 |
| Migraine Relief | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | CHAIN DRUG MARKETING ASSOCIATION, INC. | a6a07615-3108-436f-bbce-be7cb89ce456 | 2024-06-13 | Warnings | 214039 ANDA214039 |
| Migraine Relief | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | DISCOUNT DRUG MART | 0ac12ced-70b3-7bbe-e063-6394a90aad52 | 2024-06-13 | Warnings | 214039 ANDA214039 |
| Acetaminophen, Aspirin and Caffeine | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | Safrel Pharmaceuticals, LLC. | 0ac07846-5f04-dc4b-e063-6394a90ac8ca | 2023-11-22 | Warnings | 214039 ANDA214039 |
| Migraine Relief | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | AAA PHARMACEUTICAL, INC. | f9c9a0b4-dbfe-7da9-e053-6294a90a7e09 | 2023-05-03 | Warnings | 214039 ANDA214039 |
| Migraine Relief | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | FSA STORE INC. | ec6b7017-cf12-09a7-e053-2995a90a2db9 | 2023-01-12 | Warnings | 214039 ANDA214039 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 308297 | acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet | PSN | 08a46808-2bb2-0b40-e063-6394a90af80e | 3 |
| 308297 | acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet | SCD | 08a46808-2bb2-0b40-e063-6394a90af80e | 3 |
| 308297 | APAP 250 MG / ASA 250 MG / caffeine 65 MG Oral Tablet | SY | 08a46808-2bb2-0b40-e063-6394a90af80e | 3 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|
| 56062-305-02 | 56062030502 | 1 BOTTLE, PLASTIC in 1 CARTON (56062-305-02) / 50 TABLET in 1 BOTTLE, PLASTIC | 2024-02-23 | No | No | Current |